Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.

Marie-Claude Bourgeois-DaigneaultLauren Elizabeth St-GermainDominic Guy RoyAdrian PelinAmelia Sadie AitkenRozanne ArulanandamTheresa FallsVanessa GarciaJean-Simon DialloJohn Cameron Bell

Published in: Breast cancer research : BCR (2016)

The combination of MG1 and Paclitaxel improved efficacy in all of the breast cancer models we tested and thus is a promising alternative approach for the treatment of patients with refractory breast cancer. Our strategy has potential for rapid translation to the clinic, given the current clinical status of both agents.

Keyphrases

primary care
young adults
combination therapy
climate change
replacement therapy
childhood cancer
loop mediated isothermal amplification